Prevalence and Predictors of Esophageal Thermal Lesions in High-power-Short-duration Ablation of Atrial Fibrillation
VISUAL-AF
1 other identifier
observational
263
1 country
2
Brief Summary
Patients with documented atrial fibrillation who were referred to our clinic for catheter ablation will undergo standard HPSD ablation and subsequent esophagoscopy. After esophagoscopy patients will be followed up for one month in the form of a telephone follow-up. The primary endpoint of the study assessed by esophagoscopy performed on the day after the index catheter ablaton is the incidence of esophageal thermal lesions. Secondary endpoints include:
- 1.The size of the esophageal thermal lesions.
- 2.The severity of esophageal thermal lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 24, 2023
CompletedFirst Posted
Study publicly available on registry
February 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedOctober 2, 2023
January 1, 2023
2.4 years
January 24, 2023
September 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of ablation-related esophageal thermal lesions
It will be assessed by means of Esophagoscopy
One day after Catheter ablation
Secondary Outcomes (2)
Size of ablation-related esophageal thermal lesions
One day after Catheter ablation
Severity of ablation-related esophageal thermal lesions
One day after Catheter ablation
Eligibility Criteria
All patients with documented atrial fibrillation who were referred to our clinic for pulomary vein isolation
You may qualify if:
- Atrial fibrillation documented in the 12-lead ECG
- Indication for catheter ablation in accordance with currentn ESC guidelines
You may not qualify if:
- Pregnancy
- Women of childbearing potential without a negative pregnancy test within 48 hours prior to ablation procedure
- Known intracardiac or other thrombi
- Contraindication to anticoagulation
- Contraindication to esophagoscopy: diseases and deformities of the cervical spine, esophageal varices
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Arash Arya
Leipzig, Saxony, 04289, Germany
Department of Electrophysiology, Leipzig Heart Center at University of Leipzig
Leipzig, Saxony, 04289, Germany
Related Publications (1)
Wolff C, Langenhan K, Wolff M, Efimova E, Zachaus M, Darma A, Dinov B, Seewoster T, Nedios S, Bertagnolli L, Wolff J, Paetsch I, Jahnke C, Bollmann A, Hindricks G, Bode K, Halm U, Arya A. Incidence and predictors of thermal oesophageal and vagus nerve injuries in Ablation Index-guided high-power-short-duration ablation of atrial fibrillation: a prospective study. Europace. 2024 May 2;26(5):euae107. doi: 10.1093/europace/euae107.
PMID: 38646922DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gerhard Hindricks, MD
Leipzig Heart Center at University of Leipzig
- STUDY DIRECTOR
Arash Arya, MD
Leipzig Heart Center at University of Leipzig
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2023
First Posted
February 2, 2023
Study Start
March 1, 2021
Primary Completion
August 1, 2023
Study Completion
September 1, 2023
Last Updated
October 2, 2023
Record last verified: 2023-01